CA
XBI icon

CoreCap Advisors’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

CoreCap Advisors’s Portfolio XBI Stock Details XBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$196K Sell
1,240
-359
-22% -$48.5K 0.01% 869
2026
Q1 		$204K Sell
1,599
-64
-4% -$7.99K 0.01% 796
2025
Q4 		$203K Buy
1,663
+616
+59% +$70.6K 0.01% 792
2025
Q3 		$105K Hold
1,047
– – ﹤0.01% 1016
2025
Q2 		$86.8K Hold
1,047
– – ﹤0.01% 1036
2025
Q1 		$84.9K Sell
1,047
-115
-10% -$10.3K ﹤0.01% 962
2024
Q4 		$105K Sell
1,162
-300
-21% -$29.1K ﹤0.01% 912
2024
Q3 		$144K Hold
1,462
– – 0.01% 786
2024
Q2 		$136K Hold
1,462
– – 0.01% 435
2024
Q1 		$139K Buy
+1,462
New +$136K 0.01% 731
2022
Q4 		$176K Buy
+2,126
New +$172K 0.01% 570
2022
Q3 		– Sell
-2,217
Closed -$165K – 2130
2022
Q2 		$165K Buy
+2,217
New +$166K 0.01% 565
2022
Q1 		– Sell
-2,126
Closed -$238K – 2126
2021
Q4 		$238K Buy
+2,126
New +$256K 0.02% 497

Other funds holding XBI

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
PR
PSP Research Newtown Square, Pennsylvania $188M AUM
AAS
Annex Advisory Services Brookfield, Wisconsin $5.86B AUM 21.83% 1-Year Est. Return
WAM
Weatherly Asset Management Del Mar, California $1.4B AUM 36.32% 1-Year Est. Return
RFM
Royal Fund Management Lady Lake, Florida $1.2B AUM 32.21% 1-Year Est. Return
NHFG
New Harbor Financial Group Worcester, Massachusetts $633M AUM 37.53% 1-Year Est. Return
MFS
Madrona Financial Services Everett, Washington $543M AUM 30.87% 1-Year Est. Return
LRPA
L. Roy Papp & Associates Phoenix, Arizona $951M AUM 29.05% 1-Year Est. Return
SGH
Sivik Global Healthcare Greenwich, Connecticut $132M AUM 24.1% 1-Year Est. Return
EWM
Edge Wealth Management New York $594M AUM 24.92% 1-Year Est. Return

CoreCap Advisors's XBI Position: Q2 2026 in Review

CoreCap Advisors reduced its State Street SPDR S&P Biotech ETF (XBI) stake by 22% in Q2 2026, selling an estimated $48.5K and leaving 1,240 shares worth $196K. The position accounts for 0.01% of the portfolio, ranked #869.

CoreCap Advisors first reported a position in XBI in Q4 2021 and has held it in 13 quarters since. The position peaked at $238K in Q4 2021. 225 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

  • CoreCap Advisors held 1,240 shares of State Street SPDR S&P Biotech ETF worth $196K as of Q2 2026.
  • CoreCap Advisors sold 359 State Street SPDR S&P Biotech ETF shares in Q2 2026, an estimated $48.5K.
  • State Street SPDR S&P Biotech ETF made up 0.01% of CoreCap Advisors's portfolio in Q2 2026, its #869 holding.
  • CoreCap Advisors first reported a position in State Street SPDR S&P Biotech ETF in Q4 2021 and has held it in 13 quarters since.
  • CoreCap Advisors's State Street SPDR S&P Biotech ETF position peaked at $238K in Q4 2021.
  • 225 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on CoreCap Advisors's 13F filing for Q2 2026, filed 6 Jul 2026.